BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12040884)

  • 1. Surface expression of toll-like receptor 4 on THP-1 cells is modulated by Bu-Zhong-Yi-Qi-Tang and Shi-Quan-Da-Bu-Tang.
    Mita Y; Dobashi K; Shimizu Y; Nakazawa T; Mori M
    Methods Find Exp Clin Pharmacol; 2002 Mar; 24(2):67-70. PubMed ID: 12040884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The radioprotective effects of bu-zhong-yi-qi-tang: a prescription of traditional Chinese medicine.
    Kim SH; Lee SE; Oh H; Kim SR; Yee ST; Yu YB; Byun MW; Jo SK
    Am J Chin Med; 2002; 30(1):127-37. PubMed ID: 12067087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the restorative effect of Bu-zhong-yi-qi-tang in the spleen-qi deficiency rat model using (1)H-NMR-based metabonomics.
    Zheng XF; Tian JS; Liu P; Xing J; Qin XM
    J Ethnopharmacol; 2014 Feb; 151(2):912-20. PubMed ID: 24333365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 4 surface expression on human monocytes and B cells is modulated by IL-2 and IL-4.
    Mita Y; Dobashi K; Endou K; Kawata T; Shimizu Y; Nakazawa T; Mori M
    Immunol Lett; 2002 Apr; 81(1):71-5. PubMed ID: 11841848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 2 and 4 surface expressions on human monocytes are modulated by interferon-gamma and macrophage colony-stimulating factor.
    Mita Y; Dobashi K; Shimizu Y; Nakazawa T; Mori M
    Immunol Lett; 2001 Sep; 78(2):97-101. PubMed ID: 11672593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced effects of combined bu-zhong-yi-qi-tang (TJ-41) and interleukin-18 on the production of tumour necrosis factor-alpha and interferon-gamma in human peripheral blood mononuclear cells.
    Tamura R; Takahashi HK; Xue D; Kubo S; Saito S; Nishibori M; Iwagaki H; Tanaka N
    J Int Med Res; 2004; 32(1):25-32. PubMed ID: 14997702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A screening strategy for bioactive components of Bu-Zhong-Yi-Qi-Tang regulating spleen-qi deficiency based on "endobiotics-targets-xenobiotics" association network.
    Hu L; Chen J; Duan H; Zou Z; Qiu Y; Du J; Chen J; Yao X; Kiyohara H; Nagai T; Yao Z
    J Ethnopharmacol; 2023 Oct; 314():116605. PubMed ID: 37178982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective effect of oral administration of several traditional Kampo-medicines on lethal Candida infection in immunosuppressed mice].
    Abe S; Ishibashi H; Tansho S; Hanazawa R; Komatsu Y; Yamaguchi H
    Nihon Ishinkin Gakkai Zasshi; 2000; 41(2):115-9. PubMed ID: 10777823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the antitumor activity of traditional Chinese medicines. (1)].
    Ito H; Shimura K
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2145-8. PubMed ID: 4062313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The restoration of the antitumor T cell response from stress-induced suppression using a traditional Chinese herbal medicine Hochu-ekki-to (TJ-41:Bu-Zhong-Yi-Qi-Tang).
    Li T; Tamada K; Abe K; Tada H; Onoe Y; Tatsugami K; Harada M; Kubo C; Nomoto K
    Immunopharmacology; 1999 Jun; 43(1):11-21. PubMed ID: 10437652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang).
    Harada M; Seta K; Ito O; Tamada K; Li T; Terao H; Takenoyama M; Kimura G; Nomoto K
    Immunopharmacol Immunotoxicol; 1995 Nov; 17(4):687-703. PubMed ID: 8537606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiinflammatory effects of Bu-zhong-yi-qi-tang in patients with perennial allergic rhinitis.
    Yang SH; Yu CL
    J Ethnopharmacol; 2008 Jan; 115(1):104-9. PubMed ID: 17980528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulating effect of Japanese herbal (kampo) medicine, hochuekkito on upper respiratory mucosal immune system.
    Kiyohara H; Nagai T; Munakata K; Nonaka K; Hanawa T; Kim SJ; Yamada H
    Evid Based Complement Alternat Med; 2006 Dec; 3(4):459-67. PubMed ID: 17173109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocytic cell activation by Nonendotoxic glycoprotein from Prevotella intermedia ATCC 25611 is mediated by toll-like receptor 2.
    Sugawara S; Yang S; Iki K; Hatakeyama J; Tamai R; Takeuchi O; Akashi S; Espevik T; Akira S; Takada H
    Infect Immun; 2001 Aug; 69(8):4951-7. PubMed ID: 11447173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The positive role of traditional Chinese medicine as an adjunctive therapy for cancer.
    Zhang X; Qiu H; Li C; Cai P; Qi F
    Biosci Trends; 2021 Nov; 15(5):283-298. PubMed ID: 34421064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of toll-like receptor 4 in endothelial cell activation of larger vessels in response to lipopolysaccharide.
    Hijiya N; Miyake K; Akashi S; Matsuura K; Higuchi Y; Yamamoto S
    Pathobiology; 2002; 70(1):18-25. PubMed ID: 12415188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Toll-like receptors in human monocytes and dendritic cells.
    Visintin A; Mazzoni A; Spitzer JH; Wyllie DH; Dower SK; Segal DM
    J Immunol; 2001 Jan; 166(1):249-55. PubMed ID: 11123299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Erkang, a modified formulation of Chinese folk medicine Shi-Quan-Da-Bu-Tang, on mice.
    Wu Y; Zhang Y; Wu JA; Lowell T; Gu M; Yuan CS
    J Ethnopharmacol; 1998 Jun; 61(2):153-9. PubMed ID: 9683346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components.
    Dziarski R; Wang Q; Miyake K; Kirschning CJ; Gupta D
    J Immunol; 2001 Feb; 166(3):1938-44. PubMed ID: 11160242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses.
    Sabroe I; Jones EC; Usher LR; Whyte MK; Dower SK
    J Immunol; 2002 May; 168(9):4701-10. PubMed ID: 11971020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.